ViralCure Logo

Let’s(Cure)Science

Building instruments and tools to enhance private, public and community participation

#Health#Technology#DeSci#AltFunding

ViralCure's joint strategy is the tide that raises all boats

By tackling obstacles and breaking down barriers, ViralCure brings together and motivates the essential stakeholders in the biotechnological industry.

  • Public Sector

    National governments and international organizations concerned with the public provision of healthcare.

  • CROs

    Contract Research Organizations that take care of the clinical trials and the official approval of new high-end medicines.

  • Communities

    Engaged individuals who are willing to support impactful research and development.

  • CDMOs

    Contract Development and Manufacturing Organizations that ensure biopharmaceuticals are manufactured and distributed.

  • Scientists

    Researchers, laboratories and biotechs involved in healthcare science innovation.

  • Private sector

    Retail and institutional investors interested in healthcare science innovation.

How to shape the future of science

Composing local units and communities into global networks of cooperation, ViralCure allows people, scientists, and institutions to connect, work and learn together.

ViralCure App

Lets individuals directly fund and engage with impactful research and development projects in a variety of ways and at different stages.

ViralCure API

Connects public healthcare providers to the products and services of the Scientists, Biotechs and Contract Organizations in the network.

ViralCure Fund

Integrates new companies, labs and organizations into the ecosystem, enabling them to access the consulting services of top-notch experts and professionals.

Let us please introduce

The ViralCure Alliance

Mabloc Logo

Mabloc

A biotech specializing in the discovery of monoclonal antibodies against infectious diseases through its proprietary BRAID methodology.

ImmunoX Logo

ImmunoX

An early-stage biotech company developing CAR-Macrophage strategies to fight cancer.

LiqSci Logo

LiqSci

A biotech developing innovative and non-invasive diagnostic technologies to detect biomarkers for a variety of clinical conditions.

Clinergy Health Logo

Clinergy Health

A purpose-first collaborative research organization, offering cost-effective and regulatory compliant clinical research services to take biotechs' clinical development to the next level.

Biotimize Logo

Biotimize

An R&D company providing personalized biotechnology and bioprocess engineering-based services (non-GMP) to biopharmaceutical companies.

ViralCure Logo
Join Us

Scientists and Institutions already participating

ViralCure collaborates with a growing network of world renowned researchers and organizations.

Daniel Douek
Daniel Douek

M.D.Ph.D

View Profile
ViralCure TeamScientific Committee

Experience
  • Senior Investigator and the Chief of the Human Immunilogy Section, Vaccine Research Center, NIAID, National Insitutes of Health, Bethesda, USA.
  • Phd - Immunology at the University of London.
  • Appointed to the NIH Vaccine Research Center in November 2000 and NIH Director’s Award in 2008.
  • Received the World AIDS Day Award in 2007.
  • One of the world’s top 50 scientists by Scientific American in 2005.
  • Named as one of the 2012 POZ 100 for his significant contributions to accelerating the end of AIDS.
Dennis Burton
Dennis Burton

Ph.D

View Profile
ViralCure TeamScientific Committee

Experience
  • Scientific Director and Board Member - Mabloc.
  • Chair - Immunology and Microbiology, The Scripps Research Institute, US.
  • Immunologist - Massachusetts General Hospital, Harvard Medical School.
  • Fellow of American Academy of Microbiology.
  • Scientific Advisory Board Member - University of Lund, Sweden.
  • Scientific Advisory Board Member - Krebs Institute, University of Sheffiled, UK.
  • Science Committee Member - Global HIV Vaccine Initiative.
  • Ph.D. - Physical Biochemistry, University of Lund, Sweden.
  • First Class Honors - Oxford University.
Myrna Bonaldo
Myrna Bonaldo

Ph.D

View Profile
ViralCure TeamScientific Committee

Experience
  • Principal investigator at the Molecular Biology of Flavivirus Laboratory, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro.
  • Expert in the development of recombinant live-attenuated vaccines.
  • Author of 4 patents about this vaccine development method.
  • World-renowned molecular virologist.
  • Collaborated in the development of antibody immunotherapy against flaviviruses and coronaviruses.
Vanderson Rocha
Vanderson Rocha

M.D.Ph.D

View Profile
ViralCure TeamScientific Committee

Experience
  • Doctor - Biotechnological Therapy, University of Paris 7, France.
  • Professor - Hematology, Hemotherapy and Cell Therapy, Faculty of Medicine, University of São Paulo, Brazil.
  • CEO - Pro-Blood Foundation.
  • Consultant Professor - Oxford University, UK.
  • Universidade de Sao Paulo
  • National Institute of Allergy and Infectious Diseases
  • Scripps Research
  • Washington University in St. Louis (Arts & Sciences)
  • Hospital das Clinicas

The(Cure)needs to go viral

Allies collaborating with ViralCure
Sthorm Logo
PlanetaryX Logo
  • Twitter
  • LinkedIn
  • YouTube

2023 · Powered by Sthorm